LetermovirMeSH Supplementary Concept

https://www.has-sante.fr/jcms/p_3498130/fr/prevymis-letermovir-antiviral
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
infusions, intravenous
letermovir
chemoprevention
kidney transplantation
cytomegalovirus infections
adult
living donors
Cytomegalovirus antibody detected in serum (finding)
Cytomegalovirus antibody not detected in serum (finding)
Kidney Donor
evaluation of the transparency committee
letermovir
antiviral agents

---
Prevymis letermovir
https://www.ema.europa.eu/medicines/human/EPAR/Prevymis
2018
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
letermovir
drug approval
europe
treatment outcome
orphan drug production
hematopoietic stem cell transplantation
allografts
Allogeneic Hematopoietic Stem Cell Transplantation
antiviral agents
antiviral agents
cytomegalovirus infections
Cytomegalovirus infection reactivation
administration, oral
infusions, intravenous
terminase
enzyme inhibitors
enzyme inhibitors
pregnancy
breast feeding
drug interactions
letermovir
product surveillance, postmarketing
adult
aged
drug evaluation, preclinical
letermovir
letermovir
acetates
quinazolines
letermovir
endodeoxyribonucleases
acetates
quinazolines

---
https://www.has-sante.fr/portail/jcms/c_2869231/fr/prevymis
2018
false
false
false
France
French
treatment outcome
orphan drug production
hematopoietic stem cell transplantation
allografts
Allogeneic Hematopoietic Stem Cell Transplantation
antiviral agents
cytomegalovirus infections
Cytomegalovirus infection reactivation
administration, oral
infusions, intravenous
terminase
enzyme inhibitors
letermovir
adult
aged
evaluation of the transparency committee
insurance, health, reimbursement
letermovir
letermovir
acetates
quinazolines
endodeoxyribonucleases

---